In this study, we take a combination of bioinformatic, molecular, cellular, and genetic approaches and reveal a mechanism in which stromal Foxf2 suppresses prostate cancer progression and metastasis by enhancing antitumor immunity. This evidence concerns the gene FOXF2 and Familial prostate cancer.